Organon announced that Kirke Weaver has been appointed General Counsel and Corporate Secretary, and will continue as a member of Organon's executive leadership team, effective January 1, 2023. Mr. Weaver was named as the interim head of the Office of General Counsel and Corporate Secretary in July 2022. Mr. Weaver brings nearly 20 years of pharmaceutical industry experience to the role, successfully providing legal and business advice in the multi-faceted, changing healthcare environment.

Prior to serving as interim General Counsel and Corporate Secretary, Mr. Weaver served as Senior Vice President, Commercial, Regulatory, Securities, Employment and Deputy Corporate Secretary at Organon. As a senior member of the legal leadership team, he was critical to launching Organon as a standalone company in June 2021. Prior to joining Organon, Mr. Weaver was a valuable member of the legal team at Merck, known as MSD outside the United States and Canada, most recently serving as Vice President, Office of General Counsel.

He joined Merck in 2003, and held positions of increasing responsibility. He holds a B.A. from the College of William & Mary and a Juris Doctor (J.D.) degree from Yale Law School.